Product Overview
Saxenda 6mg Pen 1s is a prescription medication used for weight management in adults with obesity or those who are overweight with weight-related medical problems. It is manufactured by Novo Nordisk and contains the active ingredient Liraglutide.

Key Benefits
- Helps decrease appetite and food intake
- Aids in weight loss when used in combination with a reduced-calorie diet and increased physical activity
- Can improve metabolic health in individuals with obesity
- May reduce the risk of developing obesity-related complications

How It Works
Liraglutide, the active ingredient in Saxenda, mimics the effects of a hormone called GLP-1. This hormone helps regulate appetite, food intake, and body weight. By activating GLP-1 receptors in the brain, Saxenda can help reduce hunger and increase feelings of fullness, leading to decreased food consumption and weight loss.

Directions for Use
1. Wash your hands before using the pen.
2. Choose a different injection site each time you use Saxenda.
3. Insert a new needle before each use.
4. Inject the prescribed dose under the skin of your stomach, thigh, or upper arm.
5. Rotate injection sites within the same region to reduce the risk of skin reactions.

Precautions
- Do not use Saxenda if you have a personal or family history of thyroid cancer or multiple endocrine neoplasia syndrome type 2.
- Inform your healthcare provider about all your medical conditions and medications before starting Saxenda.
- Monitor your blood sugar regularly while taking Saxenda, especially if you have type 2 diabetes.
- Seek medical attention if you experience severe abdominal pain or have signs of pancreatitis.

Storage Instructions
Store Saxenda in the refrigerator at 36°F to 46°F (2°C to 8°C). Do not freeze, and keep it away from light. Once opened, the pen can be kept at room temperature (59°F to 86°F or 15°C to 30°C) for up to 30 days. Keep the pen cap on when not in use.

Manufacturer Information
Saxenda 6mg Pen 1s is manufactured by Novo Nordisk, a global healthcare company with a focus on diabetes care. Novo Nordisk is committed to improving the lives of people with chronic diseases through innovative treatments and patient support programs.